Acute liver injury is a disease characterized by severe liver dysfunction, caused by significant infiltration of immune cells and extensive cell death with a high mortality. Previous studies demonstrated that the α7 nicotinic acetylcholine receptor (α7nAChR) played a crucial role in various liver diseases. The hypothesis of this study was that activating α7nAChR could alleviate acute liver injury and investigate its possible mechanisms.
Acute liver injury was induced by intraperitoneal injection of lipopolysaccharide (LPS)/D-galactosamine (D-Gal) in wild type, α7nAChR knockout (α7nAChR-/-) and stimulator of interferon gene (STING) mutation (Stinggt/gt) mice in the presence or absence of a pharmacologic selective α7nAChR agonist (PNU-282987). The effects of α7nAChR on hepatic injury, inflammatory response, mitochondrial damage, necroptosis, and infiltration of immune cells during acute liver injury were assessed.
The expression of α7nAChR in liver tissue was increased in LPS/D-Gal–induced acute liver injury mice. Compared to the age-matched wild-type mice, α7nAChR deficiency decreased the survival rate, exacerbated the hepatic injury accompanied with enhanced inflammatory response and oxidative stress, and aggravated hepatic mitochondrial damage and necroptosis. Conversely, pharmacologic activation of α7nAChR by PNU-282987 displayed the opposite trends. Furthermore, PNU-282987 significantly reduced the proportion of infiltrating monocyte-derived macrophages (CD45+CD11bhiF4/80int), M1 macrophages (CD45+CD11b+F4/80+CD86hiCD163low), and Ly6Chi monocytes (CD45+CD11b+MHC [major histocompatibility complex] ⅡlowLy6Chi), but increased the resident Kupffer cells (CD45+CD11bintF4/80hiTIM4hi) in the damaged hepatic tissues caused by LPS/D-Gal. Interestingly, α7nAChR deficiency promoted the STING signaling pathway under LPS/D-Gal stimulation, while PNU-282987 treatment significantly prevented its activation. Finally, it was found that Sting mutation abolished the protective effects against hepatic injury by activating α7nAChR.
The authors' study revealed that activating α7nAChR could protect against LPS/D-Gal–induced acute liver injury by inhibiting hepatic inflammation and necroptosis possibly via regulating immune cells infiltration and inhibiting STING signaling pathway.
α7 nicotinic acetylcholine receptors are core components of the cholinergic anti-inflammatory pathway, and activation of these receptors has been shown to alleviate liver injury in experimental models of hepatic ischemia–reperfusion
The question whether activation of α7 nicotinic acetylcholine receptors may also play a protective role in acute liver injury is incompletely explored
Hepatic expression of α7 nicotinic acetylcholine receptors rapidly increased in an experimental mouse model of acute liver injury induced by intraperitoneal injection of lipopolysaccharide/D-galactosamine
Genetic deficiency of α7 nicotinic acetylcholine receptors exacerbated hepatic injury while pharmacologic activation of this receptor had opposite effects
The protective effects of α7 nicotinic acetylcholine receptors operate via alleviation of hepatic mitochondrial damage and necroptosis and may involve the stimulator of interferon gene signaling pathway